Wantai biology: it is proposed to raise no more than 3.5 billion yuan for the phase II expansion project of nine price cervical cancer vaccine
Wantai biology announced that it plans to raise no more than 3.5 billion yuan for the phase II expansion construction project of nine price cervical cancer vaccine, the industrialization project of twenty price pneumococcal polysaccharide conjugate vaccine, the construction project of Xiamen Wantai diagnostic base of Yangshengtang and the construction project of nasal spray vaccine industrial base.
This text is a result of machine translation.
Related companies：
In-depth
Healthcare
IntoCare Zhang Hui: Ingenuity Forges Quality, Continuous Improvement Safeguards Lives
In 2024, nearly all medical enterprises are exploring overseas markets. This trend is driven by an anti-corruption wave within the medical industry, the demand for financing and initial public offerings, as well as challenges such as excess production capacity. Presently, venturing abroad has become an essential developmental path for medical device enterprises. Successfully entering foreign markets is not only a crucial means for the medical industry to achieve a second grow
May 09, 2024 12:18 PM
Briefing Feb 16, 2022 03:19 PM
· Technology
Samsung Electronics union threatened to hold the first strike in the company's 53 year history
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Aug 29, 2022 05:45 PM
Apr 18, 2022 06:30 PM
Briefing Oct 19, 2021 06:56 AM
The investment banking business was strictly supervised, and seven securities companies received fines
Healthcare
Insilico Medicine (英矽智能) Signs Strategic Drug Discovery Partnership with Takeda (武田制药), Deal Worth Up to US$600 Million
Chinese AI drug discovery company Insilico Medicine (英矽智能) has signed a global strategic collaboration with Japanese pharmaceutical company Takeda (武田制药), with the total potential deal value reaching up to US$600 million. Announced in early July, the agreement marks another milestone in the international commercialization of China's AI-powered drug discovery technologies through collaboration with a leading multinational pharmaceutical company.
Jul 16, 2026 02:33 PM
Briefing Oct 18, 2021 10:49 AM
· Healthcare
Tongce medical responded to the chairman's "netizens": it is the exchange of different opinions
Briefing Oct 17, 2021 06:26 PM
· Healthcare
The first batch of "Mao" concept achievements were released, with a year-on-year growth of more than 50%
Briefing Sep 17, 2021 11:58 AM
· Technology
Amazon: the policy is consistent all over the world, and the title is not for Chinese businesses
Healthcare · Analysis
EqualOcean Releases 2026 Chinese GoGlobal HealthTech Brands Top 10 at GGF2026
SHANGHAI, June 11, 2026 — EqualOcean officially released its 2026 Chinese GoGlobal HealthTech Brands Top 10 during the GoGlobal Forum of 100 2026 (GGF2026), one of China’s leading annual forums dedicated to globalization and international business expansion.
Jun 17, 2026 02:48 PM
Briefing Sep 02, 2021 02:06 PM
· Healthcare
Medical stocks continued to decline in the afternoon, with dongfulong falling more than 15%
Briefing Sep 02, 2021 10:22 AM
· Healthcare
The biological vaccine sector weakened, and Watson biology fell more than 6%
See more
Read next
Insight
In-depth
Low-altitude Economy · Interview
A Small Aircraft, a Bigger Bet: How China's Worthy Aero Plans to Scale Up
Jul 28, 2026 03:24 PM
Insight
In-depth
Consumer Staples · Analysis
EqualOcean Releases 2026 Chinese GoGlobal Physical Retail Brands Top 10 at GGF2026
Jun 17, 2026 02:50 PM